ENTITY

Zhejiang Hisun Pharmaceutical Co, Ltd. (600267 CH)

28
Analysis
Health CareChina
Zhejiang Hisun Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical products. The Company's products include anti-tumor, anti-parasite, cardiovascular, and anti-infection drugs.
more
16 Mar 2021 09:21

Bio-Thera Solutions (688177.CH) - What's Next for Bio-Thera After R&D Setbacks and Years of Losses?

The article analyzed the concerns after the suspension of R&D of its three core products, the challenges of its listed product Qletli,and also the...

Logo
254 Views
Share
11 Mar 2021 09:37

Genor Biopharma (6998.HK) - Here Is Why the Stock Price Decreased by About 50%

This article analyzed the concerns of Genor Biopharma in terms of core products, competitive landscape, industry characteristics and the potential...

Logo
299 Views
Share
18 Feb 2021 09:54

Innovent Biologics (1801 HK) - Have the Genes to Become a Big Pharma

This article mainly analyzed Innovent in terms of its current listed products (Sintilimab, Bevacizumab, Adalimumab and Rituximab), its pipeline,...

Logo
401 Views
Share
16 Feb 2021 09:44

Pre-IPO Joinn Laboratories - The Future Performance Is Worth Looking Forward To

This article analyzed JOINN Laboratories in terms of market potential, orders in hand and newly signed orders, equity structure and talent pool,...

Logo
987 Views
Share
05 Jan 2021 09:51

Pre-IPO Bio-Thera Solutions - Insights on Pipeline and the Competitive Landscape

This article summarized the insights on major products of Bio-Thera Solutions in the pipeline and related competitive landscape with other key...

Logo
343 Views
Share
x